ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

Kurzrock and Ferrara Join UCSD Moores Cancer Center

January 25, 2013

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

What the Physician Pay Report Won’t Tell You

April 11, 2014

The Meeting At the Beverly Hills Suite: Salick, Zeneca Par Way Acrimoniously

May 2, 1997